On the other hand, avasimibe exhibits potential antitumor effects that impair proliferation and viability of tumor cells (Gao et al., 2021), and enhance the antitumor activity of mouse CD8+ effector T cells, therefore suppressing tumor growth (Börtlein et al., 2019). Here, CD8A is linked to neoplasm.